arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Pharvaris N.V.

PHVS Health Care Biotechnology: Pharmaceutical Preparations
$33.42
Today
as of Aug 5, 16:53 ET
Last 30 days -1.73% Jun 26 → Aug 05
$31.95 $33.03 $34.10 $35.18 $36.26 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$31.52
High
$31.86
Low
$30.58
Volume
$772,445
Avg Vol
$233,832
Mkt Cap
$2.2B
P/E (TTM)
—
Beta
—
52w High
$33.33
52w Low
$15.91
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 12 items

Aug 3 · 18:09 Simply Wall St.
Pharvaris (PHVS) Stock May Be Pricey After A 103% Five Year Run
Jul 31 · 13:55 Zacks
Wall Street Analysts Think Pharvaris (PHVS) Could Surge 43.03%: Read This Before Placing a Bet
Jul 24 · 11:21 Motley Fool
After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?
▸ Show all 12 press releases & news Free account →

Overview

52-week range
$16
$33
100% of range
Avg surprise (last 3)
-3.8%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
138%
EM ±23.0% · $35 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.94$-0.88$-0.82$-0.76$-0.70 Actual $-0.89Est $-0.80Actual $-0.94Est $-0.87Actual $-0.70Est $-0.76 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.70 $-0.76 +7.9% +21.4% +4.3% earnings
Tue Aug 12, 2025Jun/2025 $-0.94 $-0.87 -8.1% — — earnings
Tue May 13, 2025Mar/2025 $-0.89 $-0.80 -11.2% — -4.2% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Aug 11, 2026Jun/2026OTHER -$0.74-$0.94 +21.3%

Implied volatility — last 90 days

58%136%213%290%368% Jun 08 — IV 120% · EM ±15.8%Jun 09 — IV 126% · EM ±15.8%Jun 11 — IV 152% · EM ±16.8%Jun 12 — IV 159% · EM ±16.3%Jun 15 — IV 221% · EM ±16.0%Jun 19 — IV 99% · EM ±22.0%Jun 22 — IV 120% · EM ±25.1%Jun 23 — IV 97% · EM ±19.8%Jun 24 — IV 96% · EM ±19.3%Jun 25 — IV 91% · EM ±17.8%Jun 26 — IV 93% · EM ±17.9%Jun 29 — IV 97% · EM ±17.2%Jun 30 — IV 59% · EM ±10.1%Jul 01 — IV 101% · EM ±16.9%Jul 02 — IV 84% · EM ±13.5%Jul 03 — IV 86% · EM ±13.5%Jul 06 — IV 77% · EM ±10.7%Jul 07 — IV 104% · EM ±13.7%Jul 08 — IV 68% · EM ±8.5%Jul 09 — IV 76% · EM ±9.0%Jul 10 — IV 110% · EM ±12.1%Jul 13 — IV 143% · EM ±11.9%Jul 14 — IV 156% · EM ±11.3%Jul 15 — IV 123% · EM ±7.3%Jul 16 — IV 368% · EM ±15.4%Jul 20 — IV 74% · EM ±17.4%Jul 21 — IV 93% · EM ±21.6%Jul 22 — IV 95% · EM ±21.7%Jul 23 — IV 100% · EM ±22.4%Jul 24 — IV 100% · EM ±22.1%Jul 27 — IV 102% · EM ±21.3%Jul 28 — IV 102% · EM ±21.0%Jul 29 — IV 114% · EM ±22.9%Jul 30 — IV 111% · EM ±21.7%Jul 31 — IV 147% · EM ±28.1%Aug 03 — IV 165% · EM ±29.3%Aug 04 — IV 134% · EM ±23.0%Aug 05 — IV 138% · EM ±23.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in